| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |